Related Experiment Video
Updated: Oct 13, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
[Changes in several blood and urine parameters during combined hyperfluid therapy for the treatment of chronic
Abstract:
During the combination of oral and intravenous application of saline solution for treatment of the COPD of horses the level of hydraemia basing on the total protein concentration in the serum, the urine production and the specific weight of urine was determined. Additionally the development of serum concentration and of renal excretion rates of potassium, calcium and magnesium were ascertained. The level of hydraemia resulting from the combined method is almost identical with the solely intravenous performed hyperinfusion therapy. Due to the excessive application of fluid an extremely high level of urine production is reached which causes a reduced specific weight as well as an increased renal excretion of potassium, calcium and magnesium. The result is a real loss of electrolytes which is - apart from hydraemia - the reason for the lower level of the corresponding serum concentrations. This seems to be important, especially for potassium and magnesium, because the organism is unable to compensate the loss of these electrolytes in the same way as the loss of calcium. In connection with the renal loss of electrolytes during the high level of urine production glucosuria is observed.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations